Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-κB/NLRP3 pathways in inflammatory endothelial cells

Atherosclerosis, a chronic inflammatory disease characterized by arterial plaque formation, is one of the most prominent causes of cardiovascular diseases. However, the current treatments often do not adequately compromise the chronic inflammation-mediated plaque accumulation and the disease progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Juan, Li, Tao, Xiong, Xiaojing, Yang, Qiaoyun, Su, Zedazhong, Zheng, Minming, Chen, Qingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690998/
https://www.ncbi.nlm.nih.gov/pubmed/38037046
http://dx.doi.org/10.1186/s12951-023-02228-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690998/
https://www.ncbi.nlm.nih.gov/pubmed/38037046
http://dx.doi.org/10.1186/s12951-023-02228-z

Ejemplares similares